newsfilter
← Latest News
GlobeNewswire·

Equus Receives Notice of Non-Compliance with New York Stock Exchange Share Price Rule

  • Equus Total Return, Inc. received a notice of deficiency from the NYSE on October 6, 2026, for failing to meet the minimum average closing price of $1.00 over a consecutive 30-trading-day period as required by Section 802.01C.
  • The notice is not a delisting and does not currently impact the listing or trading of Equus Common Stock (EQS) on the NYSE.
  • The Company plans to notify the NYSE by October 20, 2026, of its intent to cure the deficiency within the six-month cure period by achieving a closing price of at least $1.00 & an average price of at least $1.00 over 30 trading days.
  • Potential remedies to regain compliance include a reverse stock split, which would satisfy the price condition if the stock exceeds $1.00 & remains above that level for 30 trading days following stockholder approval.
  • Trading will continue on the NYSE during the cure period, & the notice is not expected to affect the Company's business operations or SEC reporting requirements.